Caitlin Koski

414 total citations
14 papers, 316 citations indexed

About

Caitlin Koski is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Biomaterials. According to data from OpenAlex, Caitlin Koski has authored 14 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Biomaterials. Recurrent topics in Caitlin Koski's work include CAR-T cell therapy research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Bone Tissue Engineering Materials (5 papers). Caitlin Koski is often cited by papers focused on CAR-T cell therapy research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Bone Tissue Engineering Materials (5 papers). Caitlin Koski collaborates with scholars based in United States. Caitlin Koski's co-authors include Susmita Bose, Ashley A. Vu, Bonny Onuike, Amit Bandyopadhyay, Naboneeta Sarkar, Volker Schellenberger, Mika K. Derynck, Fiore Cattaruzza, Bryan Irving and Milton To and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Annals of Oncology.

In The Last Decade

Caitlin Koski

14 papers receiving 309 citations

Peers

Caitlin Koski

BIOMA

ONCOL

RNMI

Aygun Nasibova Azerbaijan

Zahra Pazhouhnia Iran

Chiara Migone Italy

Kyu-Sik Shim South Korea

Gökçe Erdemir Türkiye

Marwa M. Essawy Egypt

Anna Michopoulou Greece

Sreenivasa Rao Parcha India

Nannan Xue China

Aygun Nasibova Azerbaijan

Caitlin Koski

242 ×1.2

106 ×1.0

BIOMA

66 ×0.8

17 ×0.4

ONCOL

15 ×0.4

RNMI

Citations per year, relative to Caitlin Koski Caitlin Koski (= 1×) peers Aygun Nasibova

Countries citing papers authored by Caitlin Koski

Since Specialization

Citations

This map shows the geographic impact of Caitlin Koski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caitlin Koski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caitlin Koski more than expected).

Fields of papers citing papers by Caitlin Koski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caitlin Koski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caitlin Koski. The network helps show where Caitlin Koski may publish in the future.

Co-authorship network of co-authors of Caitlin Koski

This figure shows the co-authorship network connecting the top 25 collaborators of Caitlin Koski. A scholar is included among the top collaborators of Caitlin Koski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caitlin Koski. Caitlin Koski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Cattaruzza, Fiore, Milton To, Caitlin Koski, et al.. (2023). Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors. Nature Cancer. 4(4). 485–501. 50 indexed citations

Bose, Susmita, Caitlin Koski, & Arjak Bhattacharjee. (2022). 3D printed hydroxyapatite-nacre-starch based bone grafts: Evaluation of biological and mechanical properties. Journal of materials research/Pratt's guide to venture capital sources. 37(12). 2033–2044. 4 indexed citations

Cattaruzza, Fiore, Caitlin Koski, Trang Dao-Pick, et al.. (2021). Abstract PS17-11: Her2-xpat, a novel protease-activatable prodrug t-cell engager (tce), exhibits potent t-cell activation and efficacy in her2 tumors, yielding large predicted safety margins based on non-human primate (nhp). Cancer Research. 81(4_Supplement). PS17–11. 1 indexed citations

To, Milton, Michael Fox, Fiore Cattaruzza, et al.. (2021). Abstract P193: AMX-818, a novel prodrug HER2-XPAT T-cell engager (TCE) with potent T cell activation, proteolytic cleavage and efficacy in xenograft tumors, and wide safety margins in NHP (Non Human Primate). Molecular Cancer Therapeutics. 20(12_Supplement). P193–P193. 4 indexed citations

Cattaruzza, Fiore, Caitlin Koski, Milton To, et al.. (2021). Abstract 1824: HER2-XPAT, a novel protease-activatable T-cell engager (TCE) with potent T-cell activation and efficacy in solid tumors and large safety margins in non-human primate (NHP). Cancer Research. 81(13_Supplement). 1824–1824. 1 indexed citations

Koski, Caitlin, Naboneeta Sarkar, & Susmita Bose. (2020). Cytotoxic and osteogenic effects of crocin and bicarbonate from calcium phosphates for potential chemopreventative and anti-inflammatory applications in vitro and in vivo. Journal of Materials Chemistry B. 8(10). 2048–2062. 17 indexed citations

Bose, Susmita, Caitlin Koski, & Ashley A. Vu. (2020). Additive manufacturing of natural biopolymers and composites for bone tissue engineering. Materials Horizons. 7(8). 2011–2027. 88 indexed citations

Koski, Caitlin, Ashley A. Vu, & Susmita Bose. (2020). Effects of chitosan-loaded hydroxyapatite on osteoblasts and osteosarcoma for chemopreventative applications. Materials Science and Engineering C. 115. 111041–111041. 23 indexed citations

Cattaruzza, Fiore, Caitlin Koski, Daniel R. Hostetter, et al.. (2020). 1060P HER2-XPAT, a novel protease-activatable pro-drug T-cell engager (TCE), engineered to address on-target, off tumour toxicity and provide large predicted safety margins in non-human primate (NHP). Annals of Oncology. 31. S723–S723. 1 indexed citations

10.

Cattaruzza, Fiore, et al.. (2020). Abstract 3376: HER2-XPAT and EGFR-XPAT: Pro-drug T-cell engagers (TCEs) engineered to address on-target, off-tumor toxicity with potent efficacy in vitro and in vivo and large safety margins in NHP. Cancer Research. 80(16_Supplement). 3376–3376. 4 indexed citations

11.

Cattaruzza, Fiore, Caitlin Koski, Trang Dao-Pick, et al.. (2020). 613 HER2-XPAT, a novel protease-activatable prodrug T cell engager (TCE), with potent T-cell activation and efficacy in solid tumors and large predicted safety margins in non-human primate (NHP). SHILAP Revista de lepidopterología. A368.2–A369. 1 indexed citations

12.

Koski, Caitlin, et al.. (2020). HER2-XPAT, a novel protease-activatable pro-drug T cell engager (TCE), with potent T-cell activation and efficacy in solid tumors and large predicted safety margins in non-human primate (NHP). European Journal of Cancer. 138. S10–S10. 1 indexed citations

13.

Koski, Caitlin & Susmita Bose. (2019). Effects of amylose content on the mechanical properties of starch-hydroxyapatite 3D printed bone scaffolds. Additive manufacturing. 30. 100817–100817. 53 indexed citations

14.

Koski, Caitlin, Bonny Onuike, Amit Bandyopadhyay, & Susmita Bose. (2018). Starch-hydroxyapatite composite bone scaffold fabrication utilizing a slurry extrusion-based solid freeform fabricator. Additive manufacturing. 24. 47–59. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact